Ligand Pharmaceuticals Incorporated (LGND) vs Mirum Pharmaceuticals, Inc. (MIRM)
Ligand Pharmaceuticals Incorporated and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Mirum Pharmaceuticals, Inc. are of similar size ($6.1B and $5.8B). Mirum Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 54.9% against 44.0%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −139.2%) and the higher return on invested capital (8.19% vs −173.0%). Across the 16 metrics below, Ligand Pharmaceuticals Incorporated leads on 12 and Mirum Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | LGND | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.43% | 81.72% | 65.16% |
| Operating margin | 32.61% | (134.93%) | 0.00% |
| Net margin | 67.88% | (139.18%) | 0.00% |
| Free cash flow margin | 49.34% | (44.29%) | 0.00% |
| Return on equity | 21.96% | (702.97%) | (57.72%) |
| Return on assets | 12.58% | (97.15%) | (49.22%) |
| Return on invested capital | 8.19% | (172.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack